GO
Loading...

Patents

More

  • WASHINGTON, Nov 6- The controversial patent assertion company MPHJ Technology Investments has reached an agreement with U.S. authorities barring it from using phony legal threats to demand patent licensing fees from small businesses, the Federal Trade Commission said on Thursday. "A patent is not a license to engage in deception," said Jessica Rich, director of...

  • WASHINGTON, Nov 6- The U.S. Federal Trade Commission has for the first time taken action against a patent assertion entity under its consumer protection authority, the agency said on Thursday. The FTC said MPHJ Technology Investments LLC had agreed to settle charges that they used deceptive sales claims and phony legal threats in letters that accused...

  • WASHINGTON, Nov 5- A Republican takeover of the U.S. Senate has brightened prospects for an effort to fight frivolous patent litigation, although the path to success is far from clear, sources close to the lobbying effort said on Wednesday. That legislation, backed by technology companies like Cisco Systems Inc and Google Inc, stalled in the Senate amid...

  • *Cipla says launched cheaper copy of Novartis drug in Delhi. *Cipla says Novartis not making enough drug for India. Cipla, India's fourth-largest drugmaker by revenue, said because there was an urgent but unmet need for the respiratory treatment in India it has started to sell a copy of the drug in Delhi priced at a fifth of the cost of Novartis's product.

  • Patent expirations weigh on Merck  Monday, 27 Oct 2014 | 9:31 AM ET

    The "Squawk on the Street" crew discusses pressures facing Merck in regards to drugs coming off patent, and the play on pharma companies.

  • U.S. court upholds patents on Pfizer's cancer drug Thursday, 23 Oct 2014 | 8:57 AM ET

    Oct 23- A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said. Pfizer filed the lawsuit in June 2010 after Mylan attempted to market a generic version of Sutent, patented until 2021.. The case is Pfizer Inc v.

  • INSIGHT-Big Tech winning battle with 'patent trolls' Wednesday, 22 Oct 2014 | 7:00 AM ET

    Oct 22- For two decades, companies that buy software patents to sue technology giants have been the scourge of Silicon Valley. Reviled as patent trolls, they have attacked everything from Google's online ads to Apple's iPhone features, sometimes winning hundreds of millions of dollars. NetApp, a Silicon Valley maker of sophisticated data storage devices, last...

  • Oct 17- A federal appeals court said it overturned a $15.4 million verdict against card payments company VeriFone Systems Inc because a lower court judge improperly interpreted the patents it had allegedly infringed. The U.S. Court of Appeals for the Federal Circuit on Friday said a jury in 2012 had wrongly concluded that VeriFone infringed the patents of...

  • Positive for Regeneron: Cramer  Friday, 17 Oct 2014 | 9:55 AM ET

    CNBC's Jim Cramer discusses news Regeneron's drug Eylea for treating diabetic macular edema created significantly greater improvement in visual acuity compared with Lucentis.

  • WASHINGTON, Oct 16- The White House on Thursday nominated Michelle Lee to be director of the U.S. Patent and Trademark Office, which the former executive with Internet giant Google Inc has led on an acting basis since January. Her nomination is subject to approval by the U.S. Senate.

  • Beats & Bose settle lawsuit: Report  Friday, 10 Oct 2014 | 3:28 PM ET

    Apple's Beats and Bose have settled their patent infringement dispute, reports CNBC's Julia Boorstin.

  • WASHINGTON, Oct 3- The acting head of the U.S. Patent and Trademark Office, former Google Inc executive Michelle Lee, is being seriously considered to permanently head the agency, sources have told Reuters. After leaving Google and before coming to the Virginia- based patent office, Lee headed the U.S. patent office's Silicon Valley outpost.

  • WASHINGTON, Oct 3- Gay marriage may be the most anticipated issue heading for the U.S. Supreme Court, but the justices also must tackle a host of business cases as they convene for their new term, including a patent battle involving Teva Pharmaceutical Industries Ltd.. The case also has broader ramifications in the patent arena as shown by the number of businesses...

  • Oct 1- A federal jury on Wednesday said Philips Electronics NA should pay $466.8 million to Masimo Corp for having infringed two patents for technology used to help measure blood oxygen and track pulse rates. Shares of Masimo closed 12.9 percent higher, rising $2.74 to $24.02 on the Nasdaq. Jurors in Wilmington, Delaware needed less than a day of deliberations...

  • Oct 1- A federal jury on Wednesday said Philips Electronics NA should pay $466.8 million to Masimo Corp for having infringed two patents for technology used to help measure blood oxygen and track pulse rates. Shares of Masimo closed 12.9 percent higher, rising $2.74 to $24.02 on the Nasdaq. Jurors in Wilmington, Delaware needed less than a day of deliberations...

  • WiLan says loses LTE patent case against Apple Wednesday, 1 Oct 2014 | 4:56 PM ET

    TORONTO, Oct 1- Canadian patent licensing company WiLan Inc on Wednesday said a U.S. judge had ruled in favor of Apple Inc in a litigation case against it. "WiLan has been advised that Judge Dana M. Sabraw has issued a ruling today that grants Apple's motion for summary judgment," the company said in a statement, referring to Apple's move to have two patent infringement...

  • Sept 16- A federal appeals court on Tuesday threw out a jury order requiring Apple Inc to pay VirnetX Holding Corp $368.2 million in damages for infringing four patents concerning technology for providing security over the Internet.

  • Sept 16- A federal appeals court on Tuesday threw out a jury order requiring Apple Inc to pay VirnetX Holding Corp $368.2 million in damages for infringing four patents concerning technology for providing security over the Internet.

  • Crocs trying to monopolize marketplace, competitor says Thursday, 11 Sep 2014 | 5:51 PM ET

    Sept 11- A family-owned, Nevada- based shoe company is taking on the giant shoe maker Crocs, accusing it of creating a monopoly by suing smaller competitors and putting them out of business. In a lawsuit filed on Wednesday in federal court in Nevada, USA Dawgs said Crocs Inc was using "sham" patent lawsuits in order to "litigate its competition out of the market."

  • SAN FRANCISCO/ WASHINGTON, Sept 4- Nvidia Corp has sued rival chipmakers Qualcomm and Samsung Electronics, accusing both companies of infringing its patents on graphics processing technology.